Дата: 2009-06-13 22:54
??????????? ?????? ?????????????? ??????????? ????????? ? ??????? ? ?????? ????????? ????????

?????????? ???????????????? ?????????? ????????????? (????) ???? ??????? ? ??????????? ???????? A.Gruentzig ? 1979 ?. [1]. ?? ????????? 20 ??? ?? ??????? ??????? ????????? ?? ???????? ?????????? ????????????? ??? ???????? ???????? (??) [2] ?????? ? ?????????????? ??????????? ????????? ????????? ??????????? ???????????? ????????. ?????? ????, ??????????? ? ????? 80-? ????? ???????????? ?????????? ??????????? [3], ???????, ??? ????????? ????????????? ? ??????? ?? – ?????? ?????????? ? ?????? ??????????? ????? ???????: ???????????? ?????????? ???????? ? ??????, ????????? ???????? ??????? ? ???????? ??, ????????? ? 90% ? ????? ???????. ? ??????? ?? ????????????, ? ?????????? ???????? ?????????? ????? ??? ????????????????, ????????????? ????? ???? ????????? ? ??????????? ??????? ??. ????????????? ? ??????????? ?????????????? ?? ?????????????? ?????????? ?????? ????????????? ? ???? (??? ???????????) ?, ????? ????, ?????? ??????????? ??????????????? ??????? ???????? ???????????????????? ????????? ?????????? ??????? ? ??????? ?????? ?????????. ?????????? ???????, ?? ??????? ???? ????????? ?????????????, ??????????, ?? ?????? ????????? ?????????????? ????? ????????, ????? ??? ? 10% ???????.

?? ?????? ??????????? ??????? [4-8] ??? ????????????? ??????? ???? ???????? (???) (??????? ????? ??? ?????????? ????????? ????, ??? ? ???? ? ??????????? ???????????????) ??????????? ?????? ???????-???????????????? ?????? ? ???????????????? ? ????????? ? ??????????????? ?????????????? ??? ??????? ???????????. ??? ? ???????? ???????? ???????????????? ? ????????? ??????????? ?????????????? ????????? ? ??? ? ????????? ? ?????? ??. ????????????, ?????????? ??????????? ????????, ???????? ????????? ??? ? ??????? ?????? ?????????, ???????????. ???? ?????? ???????? ??????? ?????? ????????????? ? ??? ? ??????????? ????????? ??????? ??, ??? ? ???????, ?? ?????????? ????????? ??????? [4, 5, 6, 9, 10], ?????? [11, 12] ?? ????? ????? ???????????, ??????? ??????? ??????? ???????????????? ? ?????????? ??? ? ????????????? ?????????? ??????? ??, ?????? ??????? ???? ???????????????? ?????????????? ????????? ? ????? ? ?????????? ???????????????? ??????????? ???????? ??? ?????????? ? ??????????? ??????????? ???? ???????? ? ????????? ???????? ??????? ??.. ?????? ?????????????????? ???? ??????? ????????? ???????? ?????????????? ???? ???????? ? 42 ??????? ?????? ????????? ????????, ??????? ???? ????????? ???? ??????? ???? ???????? ? ?????? ???? ??????????? [40]. ? ??????????? ??? ???????????? ???? ???????? ??????????? ??????? ????????? ?????????????? ?????????????? ???? ???????? ? ???????, ??????? ? ?????? ???? ??????????? ????????? ????. ? ??????????? ??????? (95%) ???????? ?????? ? ?????????????? ???? ???????? ?? ????????????. ?????????????? ???????? ??????? ? ????????? ????????? ???????????? 53% ????????? ????????. ?? ?????????? ???????? ? 53,0±4,2 ?? 60,1±4,4%. ??? ???? ?????????? ?? ?????????? ??????????? ? ?????? ??????? ? ???????? ???????????? ?? (?? 9,5%) ? ??????? ?????? ?? (????? 45%). ? ??????? ? ??????????? ?????? ??????? ??????? ??????? ? ??????? ???????? ??????? ?? ????????? ? ???????? ????? ????. ? ??????????? ?????? ?? ?? ??????????? ?????? ? 51,0±5,8 ?? 52,0±6,0%. ?? ?????? ???????, ???? ? ?????? ???? ?? ???????? ??????????? ??????? ??????????? ??????? ? ?????????? ?????? ? ?????????????? ???? ????????.

???????????? TIMI-III B [45,48] ????? ?????? ?????????????? ?????????????, ? ??????? 1473 ??????? ? ??? ???? ??????????????? ? ?????? ?????????? ? ?????? ?????????????? ??????? ???????. ???? ??????? ? ???????????????? ???????? (?????? ?/??? ??) ?? 6 ?????? ????????? 7,2% ? ?????? ??????????? ? 7,8% ? ?????? ??????????????? ??????? (?=0,69). ?????????? ??????????? ? ??????-???? ?? ???????? ??????????? ? ????? ??? ?????????? (10,8 ? 12,2% ??????????????? ??????? ??????????????). ????? ???????, ?????? ?????????? ????????? ?? ????? ?????? ???????????? ????? ?????????????? ??? ?????? ??????? ?? ???????? ?????????. ??????, ??? ??????????????? ????? ???????????????? ??????: ???????, ????????????????? ? ??????? ??????????? ???????, ???????????? ?????????? ??????. ? ?????????? – ? 2 ???? ???? ??????????????????? ? ????????? (7,8% ?????? 14,1%; ?<0,001). ????? ? ???????????? TIMI-III B ???? ???????????????? ????????????? ???????? ???????????? ?????????? ????????? ? ????? ?? ????? ??????? ???????? – ????? ??????? ?????? 65 ???. ?? ? ?????? ????????? ? 42-? ?????? ? 7,9% ??????? ???? ?????????, ????????????????? ? ??????????? ???????, ? ? 14,8% ?? ?????? ??????????????? ??????? (?=0,02).

???????????? VANQWISH [46], ??? 916 ??????? ? ????????????? ?? ??? ????? Q ???? ??????????????? ? ?????? ?????????? ? ?????? ?????????????? ??????? ???????, ???? ?????????????? ?????????. ???? ??????? ?? ???????????? ???????? ????? ??? ????? ???????????? ????????? 24 ? 19% ? ?????? ??????????? ? ??????????????? ??????? ?????????????? (?=0,05). ????? ??????? ?????????? ? ?????? ?????????? ????????? (13% ?????? 8%) ???? ??????????? ????????? ??????????? ??????? ???????????????? ??????????? ??? ?????????? ?????? ???????? ??????????? ????????????. ??? ???? ?? ???? ???????????????? ?? ?????? ?????? ?????? ??? ?????????? ?????????????. ? ????????? ???????????? (????? 23 ???) ?????????????? ??????? ?? ?????????? ??????????? ??????? ????? ?????????? (33%) ? ?????????????? (30%) ???????? ?? ???? ???????? (?=0,35).
?? ??????? ???? ????????? ??????? ?????????? ????????????????? ????????????, ? ??????? ???????????? ????????????? ???? ???????? ???????? ? ?????????????? ??????????? ????????? ??? ??: ???????????????? ? ????????????? [13-21]. ? ?????????, ???????????? PAMI-1 ???? ????????? ? ??? ? 395 ??????? [13]. ? ??????? 12 ? ? ??????? ???????? ?? 200 ??????? ???????? ???????? ????????? ???????????? (??????????), 195 ????????? ???? ????????? ????????????? ? ??????????? (? 90% ???????) ????????? ??????????????. ? ????????????, ??????????? ? ??????? ???? (???), ???? ???????? 103 ??????? ? ??????? 12 ? ? ??????? ???????? ?? [14]. ???????? ????????? ???????????? ???????? 56 ???????, 47 ????????? ???? ??????????????? ? ?????? ?????????????. ?? ???? 47 ??????? ????????????? ???? ????????? ? 45, ?.?. ? 2 ????????? ?????????? ???????????. ????????????? ??????? ?? ? ??????? ????????????? ??? ????????? ????????????? ???????????? ? ????????????, ??????????? ? 142 ??????? ? ??????????? [15]. ??????? ???? ??????????????? ? ??????? 6 ????? ? ??????? ???????? ??: 72 ??????? ????????? ?????? ????????????, 70 – ?????? ?????????????, ??????? ?????????? ???? ????????? ? 65 ?????????.

? ???? ?? ???? ???????????? ????????? ?????????? ??????????? ? ??????? ???????? ????????? ????????? ??? ?????????? ???? ? ?????? ???????, ??????? ??????????? ????????? ?????????????. ? ????????????, ??????????? ? ??????? ???? ??????? ? ????????? ???? ?????????? ???? ????????????? (??-?? ?????????????? ?????????? ??????????? ???????). ? ?????????? ?? ???? ???? ???????????? PAMI ???? ???????? ?????? ? ??????? ? ?????????? ? ????????? ??????? ? ??????? ?????? ???????????????? ?????? (???? ?????? 70 ???, ? ???????? ???????? ????????? ? ??????? ??? ??????????? ????? 100 ? ??????). ??? ??????? ??????????? ??????? ????? ??????????? ??????? ?????????, ??? ?????????????????? ?????????? ????????? 2% ????? ?????????, ??????? ???? ????????? ?????????????, ?? ????????? ? 10,4% ????? ???????, ??????? ????????? ??????????? (?=0,01). ? ???? ????????????? ??????????? ? ?????? ????????????? ?????????? ?? 2 ?? 2,6%. ??????? ????? ????????, ??? ? ???????????? PAMI-1 ???? ???????? ???????????? ???????? ? ??????? ????????????? ? ???? ????? ???????, ??????? ??????????? ????????? ?????????????, ??? ?? ???? ?? ?????? ?????? ???????????????? ????????, ? ??????? ????????????, ? ??????? ??? ?????????? ??????????? ? 4 ???????.

?? ????????? ??????, ?????????? ? ???? ?????????????, ??? ?????? ????????? ?????: ? ??????? ???????????????? ??????? ????????? ????????????? – ??? ??????????, ?????????? ? ????? ??????????? ????? ?????????????? ??????????? ????????? ??? ??, ??? ??? ????????? ???? ? ????????? ? ??? ??? ??? ?????????? ??????? ???????????? ??????????, ??????????? ? ????????? ????????????????, ?????????? ????????? ??????????????.

? ?????????? ????????????? ???? ????????? ???????? ????????? ????????? (???????? ???? ???????, ?? ???? ??????? ??????????? ???????? ?????????????? ????????????), ? ????????? GUSTO-IIb [16]. ? ??? ???????????? ???? ???????? 1138 ??????? ??, ??????????? ? ??????? 12 ? ????? ??? ????????. ????????? ????????????? ???? ????????? ? 565, ??????????? – ? 573 ???????. ?????????, ??? ????????? ????????????? ???? ?????? ?????????? ?? ????????? ? ????????????? ??? ?????? ? ??????? 30 ????. ?? ????????????? ????????? ???? ????? ???????? ?? ????????? ? ??????????? ????? ? ?????? ???????. ???, ?? ?????? GUSTO-IIb, ????????? ?????????? ??????????, ????????? (???????????) ?? ? ??????????? ????????? ???????? 13,7% ? ?????? ???????, ??????? ??? ???????? ???????????, ?? ????????? ? 9,6% ????? ?????????, ??????? ???? ????????? ????????????? (?=0,033). ????????????? ????????? ? ?????? ????????????? ???? ??????????? ??????? ??????? ???????? ????? ???????? ? ??????????? ??????? ??????????? ? 5-?? ?? 10-? ???? ? ??????? ???????? ??. ???, ?? ?????? ???????, ????????? ?? ???? ????????????? ? ???????????? ????????? ??. ??? ?????????? ? ??????? 6 ??? ??????????? ??????? ? ????????????? ???? ???? ???????? ????????, ???????? ?? ???? ???????? ????????? ? ?????? ?????????????. ????? 6 ??? ????????? ?????????? ?? ????????? ???? ??????? ???????? ?????????????? 16,1 ? 14,1%. ?? ?????? ????????? ?????? ????????????????? ???????????? ????????????? ????????????? ????????? ????? ???????????????? ?? ????????? ? ????????????? ??? ??????? ??????? ? ???????? [17], ?????? ?? ??? ????????? ???????? ST ? ???????? ??????? ?????????? [18], ? ????? ????????? ? ?????? ?????? ???????????????? ?????? [19]. ??????????? “????????????” ???????? ?????-??? (?????? ?? ??????? ?? 3-? ?????) ? ??????? ? ????????????? ????????? ????? ????????? ????????????? ??????? C.Grines ? ?????. ? ???????????? PAMI-II [20].

????????? ?????????? ?????????? 10 ????????????????? ????????????, ? ??????? ???????????? ?????? ?????????? ???????????? ? ????????? ????????????? ??? ??. ???????????? ???? ????????? ? 2606 ???????. ? ??????? ????????????? ? ???????? ????????????????? ????????? ???????????? ????????????? [15, 19, 22, 23], ? ????? – ???????? ????????? ????????????, ??????? ? ???? ????????????? ???????? ? ??????? ????????? [13, 14, 24], ? ? ????????? – “?????????”, ?.?. ? ??????? 1,5 ? [16, 17, 18].
?????????? ??? ??????? ??? ? ??????? 30 ???? ????? ?? ? ?????? ??????? ?????????? ??????????? (n=1316), ????????? 6,5% ?? ????????? ? 4,4% ????? 1290 ?????????, ??????? ???? ????????? ????????????? (?=0,02). ??????? ????????? ????????? ? ?????? ???????????? ????????? 5,4%, ? ?????? ????????? ????????????? – 2,8% (?=0,002). ????????? ?????????? ?????????? ? ??????? ????????? ?? ?? ??????? ???????? ?????????????? 11,9 ? 7,2% (?<0,001), ??????? ????????? ?? ??????? – 2 ? 0,7% (?<0,007), ?????? ??????? ? ??????? ????????????? ? ???? ???? ??? ????? ??????????: 1,1 ? 0,1% (?<0,001). ? ????????? ???????????????? ???????? ????? ???????????: ????????? ????????????? ????? ????????????.

???? ????????, ??? ??? ???????????? ??????????? ? ??????, ????? ?? ???? ?????????????? ??????????? ?????????????????? ????????, ?? ?????????????? ???????????????? ??????? (??????), ????????? IIb/IIIa-?????????? ???????????. ?????????? ??????? ??????????? ??????? ???????, ??? ? ??????????? ???????? ?????? ?????????? ???????????????? ???????????? ?????????????? ?????????? ??????????? ? ?????????? [47].

? ????????? ????? ? ???????? ?????????? ???????????????? ?????????? ????????????? ???????? ??????? ?????????? ???????????????? ????????????? ?????????? ??????????? (??????). ???? ????????????? ?????? [28]: ??????? ??????? ?????? ?????????? ??????????? ??????, ????????? ???????? ??????? ? ???????? ?? ? ?? ??????? ???? ????????? ????????? ????????????? (??????? ?????? ?????????? ?????????? ?? 7 ?? 15%); ????????? ??????? ?????????, ??????? ????????? 20-45% ? ??????? ?????? 6 ??? ????? ?????????? ????????????? [29, 30].

??? ??????????????? ??????? [31], ? ??????????????????? [32], ? ????? ? ?????????? ????????? ????????????????? ????????????? [33-36] ???? ???????? ??????????, ????????????????? ? ?????? ?????????? ??????? ??? ??. ??? ?????? ???? ???????????? ????????????????? ?????????????, ??????????? ? ??????????? ? ????????? ?????????? ???????, ?? ??????? 112 ????? ? ?????? ?????????????, 115 – ? ?????? ?????? ?????????????. ?? ?????? 6-????????? ??????????, ?????????? ???? ????????? ?????? ? ????? ??????? (? ????? ?? ???? ??????? – 2%), ? ?????????? ????????? ????????? ???? ?????????? ??????? ? ?????? ?????????????: 1 ?????? 8, ?.?. 1% ?????? 7% (?=0,036). ? ???? ???????????? ????????? IIb/IIIa- ?????????? ??????????? ?? ??????????????. ????????????? ???????????????? ???????? ? ????? ? ????????? ?????????? “????????” ?????? ????????? ??????????? ???? ? ?????? ????????????? ?? ????????? ? ??????? ?????????????: ?????????????? ? 19 (17%) ? (4%) ??????? (?=0,0016). ?? ?????????? 6-????????? ?????????? ? ???????? ????? ??????? ? ?????? ????????????? ?????????? ??????? ??????? ???????????: 95% ?????? 80% (?=0,012). ??????, ??? ?????????? ?? ??????? ??????????? ? ????? ??????? ????????????????? ???????????? Stent-PAMI [37]. ????????????? ???????? ????????? ??????? ? ?????????? ? ????????? ????????????? ?? ??????? (??? ?????????? ? ??????? 1 ???) ? ????????? ???????? ??????????? ???????????. ?????? ?????????????? ??????????? ????????? (III ??????? ?? ????????? ???????????? TIMI) ? ??????, ????????? ???????? ??????? ? ???????? ??, ???? ??????????? ? ?????? ????????????? (92,3%), ??? ? ??????, ??? ?????????????? ?????? (88,6%). ??????, ? ?????? ????????????? ???? ??????????? ????????? ???????????????? ? ????? ? ????????? ?????? ? ???????? ???????, ?? ??????? ???? ????????? ?????????????: 0,9% ?????? 3,5% (?=0,006). ??? ?????? ? ???????? ??????? ? ???????????? ???????????? ??????????????? ?????????????????? ???????????? STENTIM-2 [38]. ?????? 1 ??? ?????????? ??????????, ??????? ????????? ?????????, ?????????? ????????? ????????????? ? ???????????? ???? ??????????? ??? ? ?????? ?????????????, ??? ? ? ??????, ? ??????? ??????????? ?????????????. ????? 6 ??? ?????? ????? ????????????? ?????????? ?? ??????????? ?? ??????? ???????? ??????????? ????????? ? ?????????? ??????????, ? ????? ?? ??????? ???????? ??????? ?????????. ??? ? ??? ????????? ????? 1 ???, ???????? ???????????? ??????? ? ?????? ?????? ????????????? ???? ?? ?????? ????????? – ?? ??????? ?????????? ?????????, ????????????? ???????, ???????????????? ? ???????? ???????, ?? ??????? ???? ????????? ????????????? (7,5% ?????? 17%). ???, ?? ?????? ???????, ??????????? ??????????? ??????? ?????????? ? ?????? ?????????????. ?????? ?????? ???????????? ???????????? STENTIM-II [39] ?? 6 ??? ????? ???????????????? ? ?????? ?????????? ??????? ?????????? ??? ????????????? ??????? ??. ??????? ????????? ???? ?????????? ???? ? ?????? ????????????? ?? ????????? ? “??????” ?????????????? (25,3% ?????? 39,6%).

?????????? ??????? ?/??? ????????????? ????? ?????????????, ? ????????? ?????????? IIb/IIIa-?????????? ???????????, ????? ???????? ?????????? ????????????? ?? ???? ???????? ??????? ???????? ?????? ? ????????? ?????????? (?????????), ? ????? ??????? ?????????? [48]. ???, ? ???????????? EPIC [41] ????????, ??? ????????? ?????????? PG IIb/IIIa ??????????? ???????? ???????????????? ????????? ???? ? ???? ?????? ??????????? ??? ?????????? ??????????. ? ???????????? RAPPORT [25] ????????? ????????????? ??????????? (??????) ??? ????????? ????????????? ? ??????? ??. ? ?????? ??????????? ??????????????? 241 ????????, ? ?????? ??????? – 242 ????????, ??????????? ? ??????? 12 ? ????? ???????? ????????, ??????? ????????????? ?????????? ????????? ?????????????. ????? 6 ??? ?????????? ????????????? ?? ?????????? ???????? ? ????????? ?????????? ??????????, ??????? ???????? ????????? ????????? ? ??????? ?????????? ???????????????? ???????? (??? ? ?????????, ??? ? ? ???????? ???????) ????? ????? ????????. ???? ?????????? ???????? 28,1% ? ?????? ??????? ? 28,2% ? ?????? ??????????? (?=0,97). ????????? ?????????? (??? ????? ??????? ???????? ????????????????) ??? ?????????? ???? ? ?????? ??????????? ??? ????? 1 ??? (5,8% ?????? 11,2%; ?=0,03), ??? ? ????? 6 ??? (17,8% ?????? 11,6%; ?=0,05). ?????????? ??? ??????, ????? ???????? ? ????????????? ?????????????? ???????? ??????????? ???????????? (???????? ?????????? ???????? ????? ???????? ?? ?????????? ?????????? ? ??????? ???????? ?????????? ????????).

? ???? ???????????? ???????, ?????????? ??????????, ?? ???????, ??? ??? ???????? ? ?????????? ????????????? (? ?????????, ? EPISTENT [26,48]), ???? ????????, ??? ??????? ? ?????? ????????? ????????????? ? ?????? ??????????? (16,6% ?????? 9,5% ? ?????? ???????; ?=0,02). ? ??????????? ????????? ????? ???????????? EPILOG [27,48] ???? ????????, ??? ??????????? ???? ???????? ??? ????????????? ?? ???? ??????????? ?????????? 70 ??/?? ? ??????????? ????????? ???????? ?? ???? ????????????? ? ????? ??????? ?/??? ?????????? ?????????????? ????? ??????????? ?? ?????? ?? ???? 200 ?.

? ???????????? RESTORE [27] ???? ??????? ???????? ????????? ?????????. ??? ????????? ????????????? ? ???????? ?????????, ??? ???? ???????? ?? ?????? ?? ??????? ???????? ????????? (?? ???? ?????????????? ? ???????????? ?????????????? ??????????). ????? ????, ?? ???? ???????? ??????? ? ??? ??????? ? ????? ??????????? ???????????.

????????????? ????? ?? ?????? ? ???????????? ????????????? ? ????????????? ??????????? ??????????? ??? ?? ???? ??????????? ???????????? ADMIRAL [42, 43], ?????????????? ??????????????, ??????? ??????, ???????-??????????????, ????????????????? ???????? ?????????, ?????????????? ???? ??? ????????????? ? ?????? 12 ????? ?? ????????????? ??????? ???. ???, ?? ?????? ???????, ?????????????? ???????????? ?????????? ??????? ????????? ? 98,6% ? ?????? ???????????. ? ??????? 30 ???? ?????????? ??????????, ??????? ????????? ??, ??????? ???????????????? ???? 20,0% ? ?????? ??????? ? 10,7% ? ?????? ??????????? (?=0,03). ???? ????????, ??? ?????????? ????????????? ? ??????????? ???????? ??????? ?????? ????????? (54,6+12,3% ?????? 51,4+12,6% ? ???????, ?<0,05). ??? ?????? ???? ???????????? ????? ? Munich Study [50], ??? ???? ??????? ??????? ??????? ?? ???? ??????????? (?? ??????????????) ?? ?????????????? ????????? ?? ? ?????????????? ??????????? ????????? ? ??????? 14 ????. ?? ????????? ?? ??????????? ???????? ??????????? ???????????? ???????? ??????? ?? ? ?????? ???????????. ?? ? ???? ?????? ??????????? ? 55,7% ?? 62,2% , ? ??????????? ?????? ? 53,5% ?? 55,9% (?=0,3 ? ?=0,003).??????? ?????????? ???? ???????? ? ???????????? PURSUIT [49], ?????? ??????? ?????????? (????????????) ??? ????????????? ??????? ????????? IIb/IIIa-?????????? ??????????? ???????????? ???? ??????????? ????, ??? ???????????, ??-???????? ??? ?????????? ?????????. ????? ???? ????????, ??? ? ?????? ???? ??????????? ??????????? ????? ? ??????????? ??????? (????????? ??????? 0.8 % ? ?????? ?????? ? 1.1% ?????? ??????).

????????? ??????? ???????????? CADILLAC (Controlled Abciximab and Device Investigation to Lower Late Angioplasty Complications) ??? ?? ?????????. ??????????????? ?????????? ??????? ?????? CADILLAC Trial ???? ???????????? ?? 72-?? ??????? ?????? ???????????? ????????? ?????????? ? 1999 ? [43]. 2081 ??????? ? ??? ?????????????????? ?????? 12 ????? ???? ??????????????? ? ????? ?? ??????? ????????? ???????: ????????? ?T?A (n = 517), ?T?A ???? ?????????? (????? ???? 12-??????? ???????; n = 52, ????????? ????????????? (n = 511), ????????????? ???? ?????????? (n = 525). ????????? ???????? ?????? ? CADILLAC ???? ???????????? ??????? ??????, ?????????? ????????, ????????? ???????????????? ? ??????? 6 ???. ?? ??????? ??????? ???????????? ???????? ? ??????? ????????????? ???? ?????????? ??????? ????? ??????? ????? ????????. ????????? ???????????????? ???? ??????????? ?????? ????, ??? ? ?????? ???? ???? ?????????? (2.30 % ?????? 0.25 %; p = 0.00. ????? ???????? ????????????? ???????? ?? ???? ??????????? (0.8 % ?????? 0.2 %). ?????? ?????????????? ??????????? ????????? (III ??????? ?? ????????? ???????????? TIMI) ? ??????, ????????? ???????? ??????? ? ???????? ?? ???? ?????????? ? 94.8 % ? ?????? ????, ? 92.1 % ? ?????? ????????????? ? ? 96.7 % ? ?????? ????????????? ?? ???? ???????????.

? ?????? ??????????? ????????? ???????????? ????? ??????? ?????, ??? ???? ????? ????????? ????????????? ??? ?? ???????????? ?????????????, ?? ????? ????? ????????? ? ???????????????? ????? ????????? IIb-IIIa-??????????. ???????? ???? ?????????, ??? ?????????? ???????? ??????????????? ??? ?????????? ??????? ?? ? ????????? ?? ??????????????, ? ?????????????? ???????????? ?????? ?????? ??????????? ????? ???????? ??????? ??? ?? [44].

????? ???????, ?????????? ???????????????? (????, ?????????????) ???????? ??????????? ??????? ?????????????? ??????????? ????????? ?? ???????-????????? ???????. ?????????? ???? ? ????????????? ???????-????????? ?????????? ??????? ? ?????? 6 – 12 ????? ????? ?????? ???????? ???????? ????????? ??????? ??????????? ???????????????? ???? ????????? ???????? ? ?????????? ???????????? ???? ???????. ?????????? ??????? ?????????? ???????? ??????????? ???????? ????????? ? ????? ?????????????? ?????????? ???????, ? ?????????, ?????????????? ?? ???????????????? ????????? ???????? ??????????? IIb-IIIa ??????? ????????? ????????? ?????? ???????? ????? ??????????? ?????????????.

??????????

1. Gruntzig A.R., Senning A., Siegenthaler W.E. Nonoprerative dilatation coronary artery stenosis: percutaneous transluminal coronary angioplasty. N Engl J Med 1979; 301: 61-68.

2. Meyer J., Merx W., Schmitz H. et al. Percutaneous transluminal coronary angioplasty immediately after streptolysis of transmural myocardial infarction. Circulation 1982; 66: 905-913.

3. Kahn J.K., Rutherford B.D., McConahay D.R. et al. Catheterization laboratory events and hospital outcome with direct angioplasty for acute myocardial infarction. Circulation 1998; 82: 1910-1915.

4. ????????? ?.?., ??????? ?.?.,??? ????? ?. ? ??. ???????????????? ????????? ????????????? ? ??????? ?????? ????????? ????????. ??????????? 1995; 6: 30.

5. Ioseliani D.G., Rogan S.V., Alkhatib E.M., Kinrus M.D. Primary PTCA in patiens with AMI: Immediate results and mid follow – up. Moscow City Center of Interventional Cardioangiology. Abstracts: 2 International Meeting on Interventional Cardiology Jerusalem, Israel, June 30 – July 3, 1997. The Journal of Invasive Cardiology 1997; 9: Suppl C: 47 C.

6. ????????? ?.?., ????? ?.?., ??????????? ?.?. ? ??. ????????? ??????????? ????? ? ??????? ?????? ????????? ? ?????????? ????? ????? ???????????????? ????????? ?????????? ????????????? ? ??????? ?????? ????????? ????????. ??????????? 1998; 10: 4-10.

7. Ioseliani D.G., Filatov A., Kluchnikov I. et al. Prognosis and left ventricular function after myocardial reperfusion in acute myocardial infarction Bakulev“s Institute for Cardiovascular Surgery, Moscow, Russia. Abstracts: 9 International Congress Nice Acropolis rench Riviera. Europian Journal of Cardiac Pacing and Electrophysiology 1994; 4: 2: 251.

8. Ioseliani D.G., Filatov A., Koval A. et al. Moscow center of Interventional Cardioangiology, Moscow, Russia. Influence of successful recanalization of the infarct-related artery on the perfusion of the peri-infarction area in patients with acute myocardial infarction. Abstracts from the International Conference on Non-Invasive Cardiology. Cardiovasc diagnosis and prognosis. 1996; 13: 69.

9. Kataro Sumii, Yasuhiko Hayashi, Yuso Oka. The short- and long term prognosis for acute myocardial infarction after emergency coronary angioplasty. Japan Circulat J 1993; 57: 12: 1137-1149.

10. ????????? ?.?., ????? ?.?., ??????? ?.?. ? ??. ?????? ??????? ?????? ????????? ???????? ????? ???????????????? ????????? ????????????? ???????????????? ???????? ???????. ???????? ?????????? ??????????? ????? ???: ??????, ?????? 20-23 ??? 1997; 105.

11. Brodie B.R., Grines C.L., Ivanchoe R. Six-month clinical and angiographic follow up after direct angioplasty for acute myocardial infarction . Final results from Primaly Angioplasty Registiy. Circulation 1994; 90: 1: 156-162.

12. Christophe Bauters, Patrick Khanoyan. Restenosis after delayet Coronary Angioplasty of the Culprit Vessel in patiens with arescut myocardial infarction treated by thrombolysis. Circulation 1995; 91: 454-457.

13. Grines C.L., Browne K.F., Marco J. et al. A comparison of immediate angioplasty with thrombolytic therapy for acute myocardial infarction. N Engl J Med 1993; 328: 673-679.

14. Gibbons R.J., Holmes D.R., Reeder G.S. et al. Immediate angioplasty compared with the administration of a thrombolytic agent followed by conservative treatment for myocardial infarction. N Engl J Med 1993; 328: 685-691.

15. Zijlstra F., Jan de Boer M.J., Hoorntje J.C.A. et al. A comparison of immediate angioplasty with intravenous streptokinase in acute myocardial infarction. N Engl J Med 1993; 328:680-684.

16. The Global Use of Strategies to Open Occluded Coronary Arteries in Acute Coronary Syndromes GUSTO IIb Angioplasty Substudy Investigators. A clinical trail comparing primary coronary angioplasty with tissue plasminogen activator for acute myocardial infarction. N Engl J Med 1997; 336:1621-1628.

17. Garcio E., Elizaga J., Soriano J. et al. Primary angioplasty versus thrombolysis with t-PA in the anterior myocardial infarction. J Am Coll Cardiol 1997; 29: Suppl A; 389.

18. Ribichini F., Steffenino G., Dellavalle A. et al. Primary angioplasty versus thrombolysis in inferior acute myocardial infarction with anterior ST-segment depression: a single- center randomized study. J Am Coll Cardiol 1996; 27: A221.

19. Zijlstra F., Beukema W.P., van“t Hot A.W. et al. Randomized comparison of primary coronary angioplasty with thrombolytic therapy in low risk patients with acute myocardial infarction. J Am Coll Cardiol 1997; 29: 908-912.

20. Grines C.L., Marsalese D.L., Brodie B. et al. For the PAMI-II Investigators. Safety and cost- effectiveness of early discharge after primary angioplasty in low risk patients with acute myocardial infarction. J Am Coll Cardiol 1998; 31: 967-972.

21. Weaver W.D., Simes J.R., Betriu A. et al. Comparison of primary coronary angioplasty and intravenous thrombolytic therapy for acute myocardial infarction. JAMA 1997; 287: 23: 2093-2098.

22. Ribeiro E.E., Silva I.A., Carneiro R. et al. Randomized trial of direct coronary angioplasty versus intravenous streptokinase in acute myocardial infarction. J Am Coll Cardiol 1993; 22: 376-380.

23. Grinfeld L., Berrocal D., Belardi J. et al. Fibrinolytics vs primary angioplasty in acute myocardial infarction (FAP). J Am Coll Cardiol 1996; 27: Suppl: A 222.

24. DeWood M.A. Direct PTCA vs intravenous t-PA in acute myocardial infarction: results from a prospective randomized trial. In: Proceedings from the Thrombolysis and Interventional Therapy in Acute Myocardial Infarction Simposium VI. Washington, DC: George Washington University 1990; 28-29.

25. The Task Force on the Management of Acute Myocardial Infarction of the European Society of Cardiology: Acute Myocardial Infarction: Pre-hospital and in-hospital management. Eur Heart J 1996; 17: 43-63.

26. Tiefenbrunn A.J., Chandra N.C., Every N.R. et al. High mortality in patients with myocardial infarction transferred for primary angioplasty: a report from the National Registry of Myocardial Infarction-2. Circulation 1997; 96: Suppl: I-531.

27. Ohman E.M., Lincoff A.M., Bode C. et al. Enhanced early reperfusion at 60 minutes with low-dose reteplase combined with full-dose abciximab in acute myocardial infarction: preliminary result from the GUSTO-4 pilot (SPEED) dose-ranging trial (abstract). Circulation 1998; 98: Suppl: I-504.

28. ???????????? ?.?., ?????? ?.?. ?????? ??? ????????? ????????????? ? ??????? ????????? ????????. ??????????? 1999; 7: 60.

29. De Boyer M.J., Suryaprarata H., Hoorntje et al. Limitation of infarct size and preservation of left ventricular function after primary coronary angioplasty compared with intravenous streptokinase in acute myocardial infarction. Circulation 1994; 90: 753-761.

30. Suryaprarata H., van“t Hot A.W., Hoorntje et al. Randomized comparison of coronary stenting with balloon angioplasty in selected patients with acute myocardial infarction. Circulation 1998; 97: 2502-2505.

31. Katz S., Green S.J., Ong L.Y., Chepurko L. Intracoronary stenting in direct infarct angioplasty: experience with 117 consecutive cases (abstract). Circulation 1998; 98: Suppl: 1-576.

32. Mahdi N.A., Lopes J., Leon N. et al. Comparison of primary coronary stenting to primary balloon angioplasty with stent bailout for the treatment of patients with acute myocardial infarction. Am J Cardiol 1998; 81: 957-963.

33. Zidar J.P., Kruse K.R., Thel M.C. et al. Integrelin for emergency coronary artery stenting. The IMPACT II Investigators. J Am Coll Cardiol 1996; 27: 138A.

34. Hoorntje J.C., Suryaprarata H., de Boer M.J. et al. Primary stenting for acute myocardial infarction: preliminary results of a randomized trial. Emergency Stenting Compared to Conventional Balloon Angioplasty Randomized (ESCOBAR) Trial. Circulation 1996; 94: 1-570.

35. Antoniucci D., Santoro G.M., Bologness L. et al. Elective stenting in acute myocardial infarction: preliminary results of the Florence Randomized Elective Stenting in Acute Coronary Occlusion (FRESCO) study. J Am Coll Cardiol 1997; 29: 456A.

36. Rodrigues A., Fernandes M. Bernardi V. et al. Coronary stents improve hospital results during coronary angioplasty in acute myocardial infarction: preliminary results of the randomized controlled study (GRAMI trial). J Am Coll Cardiol 1997; 29: 221A.

37. Grines C.I. Primary angioplasty in myocardial infarction trial (Stent-PAMI). J Am Coll Cardiol 1998; 32: 4.

38. Maillard L., Hamon M., Monassier J.-P. et al. STENTIM 2: six months angiographic results. Elective Wiktor stent implantation in acute myocardial infarction compared with balloon angioplasty (abstract). Circulation 1998; 98: Suppl: 1-21.

39. Ong L.Y., Katz S., Green S.J. et al. Routine stenting for acute myocardial infarction results in six months outcomes comparable to patients with elective stenting (abstract). Circulation 1998; 98: Suppl: 1-577.

40. ??????????? ?.?., ????????? ?.?. ???????? ?????????????? ??????? ???????? ? ?????????????? ????????? ?????? ????????? ? ??????? ?????? ????????? ???????? ????? ???????????????? ????????? ?????????? ?????????????. ??????????? 1998; 11: 9.

41. Penn I.M., Ricci D.R., Almond D.G. et al. Stenting results in increased early complications and fewer late reinterventions: Final clinical data from the Trial of Angioplasty and Stents in Canada–1 (TASC–1). Circulation 1995; 92: Suppl. 1–475.

42. Montalescot G. The ADMIRAL study: Abciximab with percutaneous transluminal coronary angiopasty and stent in acute myocardial infarction. Presented at the American College of Cardiology 48th Scientific Session, New Orleans, March 7, 1999.

43. Gruberg G. et al. Platelet glycoprotein IIb-IIIa receptor antagonists during primary angiopasty and stenting for accurate myocardial infarction. Cardiology International 2000; Aut: 30.

44. Wu K.C., Zerhouni E.A., Judd R.M. et al. Prognostic significance of microvascular obstruction by magnetic resonanse imaging in patients with acute myocardial infarction. Circulation 1998; 97: 765–772.

45. TIMI-III B Investigators. Effects of tissue plasminogen activator and a comparison of early invasive and conservative strategies in unstable angina and non-ST elevation myocardial infarction: results of the TIMI-III B trial. Circulation 1994; 89: 1545–1556

46. Boden W.E., O“Rourke R.A., Crawford M.H. et al. For the Veterans Affairs Non-Q-Wave Infarction Strategies in Hospital (VANQWISH) Trial Investigators. Outcomes in patients with acute Non-Q-Wave myocardial infarction randomly assigned to an invasive as compared with a conservative management strategy. N Engl J Med 1998; 338: 1785-1792.

47. Garbatz E., Steg P.G., Vahanian A. Most unstable angina patients benefit from an aggressive approach to early intervention. Eur Heart J 1999; 1: Suppl N:13-19.

48. Bertrand M.E., Chair, Simoons M.L. et al. Management of acute coronary syndromes: acute coronary syndromes without persistent ST segment elevation. Recommendations of the Task Force of the European Society of Cardiology. Eur Heart J 2000; 21: 1406-1432

49. The PURSUIT Trial Investigators. Inhibition of platelet glycoprotein IIb-IIIa with Eptifibatide in patients with acute coronary syndromes. N Engl J Med 1998; 7: 436.

50. Morris DC. Results from the late-breaking clinical trials session at ACCIS“99 and ACC“99. J Am Coll Cardiol 1999; 34: 1-8.

????????? ?.?., ???????? ?.?., ??????????? ????????, ??????? ??????? ???, ??????? ????? ??????????? ??????????? ? ????????-?????????? ????????, ??????? ??????????? ???????? ?1, ??????????
http://e-cardio.ru/text/515

Наверх страницы